Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 144
Filter
1.
Br J Soc Psychol ; 59(3): 694-702, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-2278055

ABSTRACT

In this paper, we analyse the conditions under which the COVID-19 pandemic will lead either to social order (adherence to measures put in place by authorities to control the pandemic) or to social disorder (resistance to such measures and the emergence of open conflict). Using examples from different countries (principally the United Kingdom, the United States, and France), we first isolate three factors which determine whether people accept or reject control measures. These are the historical context of state-public relations, the nature of leadership during the pandemic and procedural justice in the development and operation of these measures. Second, we analyse the way the crisis is policed and how forms of policing determine whether dissent will escalate into open conflict. We conclude by considering the prospects for order/disorder as the pandemic unfolds.


Subject(s)
Betacoronavirus , Civil Disorders , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , COVID-19 , Civil Disorders/legislation & jurisprudence , Civil Disorders/psychology , Communicable Disease Control/legislation & jurisprudence , Conflict, Psychological , Coronavirus Infections/epidemiology , Coronavirus Infections/psychology , France/epidemiology , Government , Health Policy/legislation & jurisprudence , Humans , Pneumonia, Viral/epidemiology , Pneumonia, Viral/psychology , Public Opinion , Risk Reduction Behavior , SARS-CoV-2 , Social Justice , United Kingdom/epidemiology , United States/epidemiology
8.
N Engl J Med ; 387(21): 1935-1946, 2022 11 24.
Article in English | MEDLINE | ID: covidwho-2106628

ABSTRACT

BACKGROUND: In February 2022, Massachusetts rescinded a statewide universal masking policy in public schools, and many Massachusetts school districts lifted masking requirements during the subsequent weeks. In the greater Boston area, only two school districts - the Boston and neighboring Chelsea districts - sustained masking requirements through June 2022. The staggered lifting of masking requirements provided an opportunity to examine the effect of universal masking policies on the incidence of coronavirus disease 2019 (Covid-19) in schools. METHODS: We used a difference-in-differences analysis for staggered policy implementation to compare the incidence of Covid-19 among students and staff in school districts in the greater Boston area that lifted masking requirements with the incidence in districts that sustained masking requirements during the 2021-2022 school year. Characteristics of the school districts were also compared. RESULTS: Before the statewide masking policy was rescinded, trends in the incidence of Covid-19 were similar across school districts. During the 15 weeks after the statewide masking policy was rescinded, the lifting of masking requirements was associated with an additional 44.9 cases per 1000 students and staff (95% confidence interval, 32.6 to 57.1), which corresponded to an estimated 11,901 cases and to 29.4% of the cases in all districts during that time. Districts that chose to sustain masking requirements longer tended to have school buildings that were older and in worse condition and to have more students per classroom than districts that chose to lift masking requirements earlier. In addition, these districts had higher percentages of low-income students, students with disabilities, and students who were English-language learners, as well as higher percentages of Black and Latinx students and staff. Our results support universal masking as an important strategy for reducing Covid-19 incidence in schools and loss of in-person school days. As such, we believe that universal masking may be especially useful for mitigating effects of structural racism in schools, including potential deepening of educational inequities. CONCLUSIONS: Among school districts in the greater Boston area, the lifting of masking requirements was associated with an additional 44.9 Covid-19 cases per 1000 students and staff during the 15 weeks after the statewide masking policy was rescinded.


Subject(s)
COVID-19 , Health Policy , Masks , School Health Services , Universal Precautions , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Incidence , Poverty/statistics & numerical data , Schools/legislation & jurisprudence , Schools/statistics & numerical data , Students/legislation & jurisprudence , Students/statistics & numerical data , Health Policy/legislation & jurisprudence , Masks/statistics & numerical data , School Health Services/legislation & jurisprudence , School Health Services/statistics & numerical data , Occupational Groups/legislation & jurisprudence , Occupational Groups/statistics & numerical data , Universal Precautions/legislation & jurisprudence , Universal Precautions/statistics & numerical data , Massachusetts/epidemiology , Communicable Disease Control/legislation & jurisprudence , Communicable Disease Control/statistics & numerical data
11.
J Med Virol ; 92(7): 863-867, 2020 07.
Article in English | MEDLINE | ID: covidwho-1763253

ABSTRACT

With multiple virus epicenters, COVID-19 has been declared a pandemic by the World Health Organization. Consequently, many countries have implemented different policies to manage this crisis including curfew and lockdown. However, the efficacy of individual policies remains unclear with respect to COVID-19 case development. We analyzed available data on COVID-19 cases of eight majorly affected countries, including China, Italy, Iran, Germany, France, Spain, South Korea, and Japan. Growth rates and doubling time of cases were calculated for the first 6 weeks after the initial cases were declared for each respective country and put into context with implemented policies. Although the growth rate of total confirmed COVID-19 cases in China has decreased, those for Japan have remained constant. For European countries, the growth rate of COVID-19 cases considerably increased during the second time interval. Interestingly, the rates for Germany, Spain, and France are the highest measured in the second interval and even surpass the numbers in Italy. Although the initial data in Asian countries are encouraging with respect to case development at the initial stage, the opposite is true for European countries. Based on our data, disease management in the 2 weeks following the first reported cases is of utmost importance.


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Health Policy/legislation & jurisprudence , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Public Health/legislation & jurisprudence , Asia/epidemiology , COVID-19 , Communicable Disease Control , Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Europe/epidemiology , Humans , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Quarantine/organization & administration , SARS-CoV-2 , Time Factors , World Health Organization
12.
13.
JAAPA ; 34(6): 1-4, 2021 Jun 01.
Article in English | MEDLINE | ID: covidwho-1684812

ABSTRACT

ABSTRACT: Preliminary data suggest that opioid-related overdose deaths have increased subsequent to COVID-19. Despite national support for expanding the role of physician assistants (PAs) and NPs in serving patients with opioid use disorder, these clinicians are held to complex and stringent regulatory barriers. COVID-19 triggered significant changes from regulatory and federal agencies, yet disparate policies and regulations persist between physicians and PAs and NPs. The dual epidemics of COVID-19 and opioid use disorder highlight the inadequate infrastructure required to support patients, communities, and clinicians, and may serve as the catalyst for eliminating barriers to care.


Subject(s)
COVID-19/epidemiology , Health Services Accessibility/legislation & jurisprudence , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/epidemiology , Buprenorphine/therapeutic use , COVID-19/prevention & control , Drug Prescriptions , Health Policy/legislation & jurisprudence , Humans , Legislation, Drug , Narcotic Antagonists/therapeutic use , Nurse Practitioners/legislation & jurisprudence , Opioid Epidemic , Physician Assistants/legislation & jurisprudence , Physicians/legislation & jurisprudence , SARS-CoV-2 , Telemedicine , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL